Looks like the trial design wasn't good but I can't determine if that is ACW's fault or just had to be explored.
Anyway, they are most likely to redesign and maybe start a new trial.
GLTA
Ann: ACW XanaCIDD phase 2a trial topline results, page-54
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.045(59.2%) |
Mkt cap ! $84.06M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.7¢ | 2.5¢ | $3.093M | 99.90M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2638151 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 1623309 | 5 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| ACW (ASX) Chart |